Loading...
Loading...
FTRE| Name | Value |
|---|---|
| Revenues | 793.0M |
| Cost of Revenue | 649.4M |
| Gross Profit | 143.6M |
| Operating Expense | 105.9M |
| Operating I/L | 33.8M |
| Other Income/Expense | 5.1M |
| Interest Income | 0.0M |
| Pretax | 38.9M |
| Income Tax Expense | 10.6M |
| Net Income/Loss | 30.8M |
Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry, offering phase I-IV clinical trial management, clinical pharmacology, technology-enabled trial solutions, and post-approval services. The company generates revenue by providing these services to pharmaceutical, biotechnology, and medical device organizations.
